Luye Pharma Group Ltd., founded in 1994 and listed on the main board of HKSE in .HK), is a R&D driven specialty pharmaceutical company focusing on developing differentiated and “high barrier to entry” formulations. The company has state-of-the-art production facilities and R&D centers located in China, U.S.A. and Europe, as well as overseas branch offices in Hong Kong, Singapore and Malaysia with approximately 4,000 employees.

Luye Pharma focuses on developing, producing, marketing and selling innovative pharmaceutical products in four of the largest and fastest growing therapeutic areas - oncology, cardiovascular, metabolism and the central nervous system. The company has a portfolio of over 30 products. The business of Luye Pharma covers global main pharmaceutical markets including China, U.S.A., Europe, Australia, Japan, South Korea, and numerous APAC and LATAM countries. Luye Pharma has established a professional R&D system of international standard and reached inter...